Trimas Corporation (TRS) 17.69 $TRS TriMas Corporation

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trimas Corporation (TRS) 17.69 $TRS

TriMas Corporation Reports Second Quarter 2016 Results
GlobeNewswire - Thu Jul 28, 7:02AM CDT
Achieved Second Quarter 2016 EPS, Excluding Special Items, of $0.34, an increase of 13.3%
TRS: 17.69 (-0.18)

TriMas Appoints Thomas A. Amato President and Chief Executive Officer
GlobeNewswire - Thu Jul 28, 6:55AM CDT
The TriMas Corporation (NASDAQ:TRS) Board of Directors today announced that Thomas A. Amato, 52, has been appointed president and chief executive officer, effective immediately, succeeding David M. Wathen, who has stepped down from these positions and from the TriMas Board of Directors. Amato will also be appointed to the TriMas Board of Directors.
MPG: 15.49 (-0.40), TRS: 17.69 (-0.18)

Metal Fabrication Stocks Earnings on Jul 28: TKR, TRS & More
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 8:44AM CDT
A few metal fabrication companies are slated to report their second-quarter results on Jul 28.
CENX: 7.11 (-0.48), TRS: 17.69 (-0.18), TKR: 33.61 (+0.16), BOOM: 10.26 (+0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of TriMas Corporation - TRS
ACCESSWIRE - Wed Jul 06, 1:23PM CDT
NEW YORK, NY / ACCESSWIRE / July 6, 2016 / Levi & Korsinsky announces it has commenced an investigation of TriMas Corporation (NASDAQ: TRS) concerning possible breaches of fiduciary duty by the board of directors of the company. To obtain additional information, go to: http://zlk.9nl.com/trimas-trs or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
TRS: 17.69 (-0.18)

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TriMas Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Wed Jul 06, 6:11AM CDT
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of TriMas Corporation (NASDAQ: TRS).
TRS: 17.69 (-0.18)

TriMas Corporation to Present at the Deutsche Bank 2016 Global Industrials and Materials Summit
GlobeNewswire - Wed Jun 01, 9:00AM CDT
TriMas Corporation (NASDAQ:TRS) - a diversified global manufacturer of engineered and applied products - today announced that TriMas management is scheduled to present at the Deutsche Bank 2016 Global Industrials and Materials Summit on Wednesday, June 8, 2016 at 11:20 a.m. CT in Chicago. The live webcast will be available in the Investor Relations section of the Company's website at www.trimascorp.com or at https://cc.talkpoint.com/deut001/060816a_ae/?...=2_FB61G5R.
TRS: 17.69 (-0.18)

TriMas Corporation to Present at Wells Fargo Securities Industrial and Construction Conference
GlobeNewswire - Tue May 03, 9:00AM CDT
TriMas Corporation (NASDAQ:TRS) - a diversified global manufacturer of engineered and applied products - today announced that TriMas management is scheduled to present at the Wells Fargo Securities Industrial and Construction Conference on Tuesday, May 10, 2016 at 9:55 a.m. ET in New York City. The live webcast will be available in the Investor Relations section of the Company's website at www.trimascorp.com or at https://cc.talkpoint.com/well001/051016a_ae/?...=1_L56ET8C.
TRS: 17.69 (-0.18), WFC: 47.81 (-0.16)

TriMas (TRS) Tops Q1 Earnings & Sales, Keeps 2016 View
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:58AM CDT
TriMas' (TRS) first-quarter 2016 earnings & sales beat the Zacks Consensus Estimate.
CENX: 7.11 (-0.48), TRS: 17.69 (-0.18), BRSS: 27.85 (-0.47)

TriMas Corporation Reports First Quarter 2016 Results
GlobeNewswire - Thu Apr 28, 7:00AM CDT
Achieved First Quarter 2016 EPS of $0.27; Top-end of Previously Provided Guidance Range
TRS: 17.69 (-0.18)

TriMas Announces First Quarter 2016 Earnings Conference Call Date
GlobeNewswire - Tue Apr 19, 9:00AM CDT
TriMas Corporation (NASDAQ:TRS) - a diversified global manufacturer of engineered and applied products - announced today that it will host its first quarter 2016 earnings conference call on Thursday, April 28, 2016. The conference call will begin at 10 a.m. Eastern Time and will follow the Company's release of first quarter 2016 earnings results at 8 a.m. that day.
TRS: 17.69 (-0.18)

Josh Sherbin Promoted to Senior Vice President, General Counsel and Chief Compliance Officer for TriMas Corporation
GlobeNewswire - Thu Apr 14, 1:00PM CDT
TriMas Corporation (NASDAQ:TRS) - a diversified global manufacturer of engineered and applied products - today announced that Josh Sherbin, TriMas Corporation's vice president, general counsel and chief compliance officer, has been promoted to senior vice president, general counsel and chief compliance officer.
TRS: 17.69 (-0.18)

TriMas (TRS) Focuses on Profits Despite Macro Challenges
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 2:10PM CDT
On March 14, 2016 we issued an updated research report on TriMas Corporation (TRS).
TRS: 17.69 (-0.18), BRSS: 27.85 (-0.47), BGG: 22.54 (-0.19), HZN: 12.99 (-0.06)

TriMas to Present at Annual ROTH Conference
GlobeNewswire - Mon Mar 07, 9:00AM CST
TriMas Corporation (NASDAQ:TRS) - a diversified global manufacturer of engineered and applied products - today announced that TriMas management is scheduled to present at the 28th Annual ROTH Conference on Monday, March 14, 2016 at 1 p.m. PT in Dana Point, California. The live webcast will be available in the Investor Relations section of the Company's website at www.trimascorp.com or at http://wsw.com/webcast/roth30/trs.
TRS: 17.69 (-0.18)

BUYINS.NET: SSO, TSL, CSJ, CPLP, TRS, CZZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jan 26, 8:00AM CST
www.squeezetrigger.com is monitoring the Seasonality of Silver Standard Resources Inc (NYSE:SSO), Trina Solar Ltd (NYSE:TSL), iShares Barclays 1-3 Year Credit Bond Fund (NYSE:CSJ), Capital Product Partners LP (NASDAQ:CPLP), Tres-Or Resources Ltd (NASDAQ:TRS), Cosan Limited (NYSE:CZZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
TRS: 17.69 (-0.18), CZZ: 6.39 (-0.29), SSO: 71.02 (-0.14), CPLP: 3.62 (-0.15), SSRI: 14.12 (+0.18), TSL: 10.33 (+2.08), CSJ: 105.85 (-0.23)

TriMas Hosting Investor Meeting and Tour Today at Aerospace Business
GlobeNewswire - Wed Jan 20, 11:00AM CST
TriMas Corporation (NASDAQ:TRS) - a diversified global manufacturer of engineered and applied products - announced that it is hosting an investor and analyst meeting today regarding its Aerospace segment, at its facility in City of Industry, California.
TRS: 17.69 (-0.18)

TriMas' Rieke Establishes Global Innovation Center in India
BusinessWire - Tue Dec 15, 9:00AM CST
TriMas Corporation (NASDAQ: TRS) - a diversified global manufacturer of engineered and applied products - announced today that Rieke Packaging has opened its Global Innovation Center in Asia. Based outside Delhi, India, this center houses a cross-functional team of product development, sales, marketing, customer service and supply chain experts. This team is focused on driving innovation across its broad range of packaging solutions for its customers in the industrial, food & beverage, and health, beauty and home care markets.
TRS: 17.69 (-0.18)

Today's Market Driven by Key Factors - Analyst Notes on Arrowhead Research, Omeros Corp, TriMas and Applied Micro Circuits
ACCESSWIRE - Fri Dec 11, 6:30AM CST
NEW YORK, NY / ACCESSWIRE / December 11, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Arrowhead Research Corp (NASDAQ: ARWR), Omeros Corp (NASDAQ: OMER), TriMas Corp (NASDAQ: TRS) and Applied Micro Circuits Corp (NASDAQ: AMCC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
TRS: 17.69 (-0.18), ARWR: 5.86 (-0.10), AMCC: 6.71 (+0.13), OMER: 11.80 (+0.04)

Pentair (PNR) Rewards Shareholders with 5% Dividend Hike
Zacks Equity Research - Zacks Investment Research - Wed Dec 09, 1:55PM CST
Pentair plc (PNR) has raised the company's annual dividend by 5% to $1.32 per share.
JBT: 66.99 (+0.07), TRS: 17.69 (-0.18), WOR: 43.96 (-0.35), PNR: 62.29 (-1.53)

ABB Offers Avant-Garde Technology for Chinese Substations
Zacks Equity Research - Zacks Investment Research - Thu Dec 03, 12:50PM CST
ABB Ltd. (ABB) recently unveiled its plans to initiate the installment of "integrated smart grid-enabled switchgear" substations in Northwest China.
TRS: 17.69 (-0.18), ABB: 21.07 (-0.18), CUI: 4.87 (-0.08), DY: 93.78 (-0.27)

13.8% Return Seen to Date on SmarTrend Trimas Call (TRS)
Comtex SmarTrend(R) - Tue Dec 01, 9:35AM CST
SmarTrend identified an Uptrend for Trimas (NYSE:TRS) on October 8th, 2015 at $18.94. In approximately 2 months, Trimas has returned 13.78% as of today's recent price of $21.55.
TRS: 17.69 (-0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Eli Lilly's Pirtobrutinib Shows Promising Results in CLL Trials

Updated Category News Views 158

Pirtobrutinib's Efficacy in Chronic Lymphocytic Leukemia Studies Eli Lilly and Company (NYSE: LLY) made notable advancements in chronic lymphocytic leukemia (CLL) research with their drug, pirtobrutinib. The recent study, known as BRUIN CLL-321, demonstrated that pirtobrutinib significantly reduced the risk of disease progression or death by 46% compared to previous...

Continue Reading
Exploring Axon Enterprise's Options Trading Dynamics

Updated Category News Views 173

Investors' Insights on Axon Enterprise In the ever-evolving world of stock market investments, insights from institutional and wealthy individual investors can carry significant weight. Recently, there has been a noticeable bullish stance on Axon Enterprise (NASDAQ: AXON), raising curiosity among retail traders about potential future movements. Unusual Options Activity...

Continue Reading
Aventis Energy Releases Technical Report on Corvo Project

Updated Category News Views 143

Aventis Energy Files NI 43-101 Technical Report on Corvo Project Aventis Energy Inc. (“Aventis” or the “Company”) (CNSX: AVE | Frankfurt: C0O0 | Other OTC: VBAMF) is excited to announce that its partner, Standard Uranium Ltd., has filed a technical report detailing findings and exploration data from the Corvo Project. This report, titled "Technical Report on the...

Continue Reading
Drucker + Falk Celebrates Community Commitment Through Cleanup Events

Updated Category News Views 108

Drucker + Falk's Dedication to Community Engagement Drucker + Falk, a prominent name in multifamily property management, has made remarkable strides in community involvement through its annual clean-up initiatives. This year, they marked the third consecutive clean-up campaign aimed at enhancing local environments, aligning their efforts with the mission of Keep America...

Continue Reading
Exploring the Future of Mental Health: The Wholeness Center

Updated Category News Views 96

Revolutionizing Mental Health with Integrative Approaches The Wholeness Center has gained state approval to offer legal psilocybin-assisted therapy, marking a significant milestone as the sole licensed healing center in Northern Colorado. This innovative facility combines the realms of psychedelic therapy with integrative psychiatry, aiming to provide comprehensive mental...

Continue Reading